#1 Clinical Trials Search in Europe

Clinical Trials By Country

Explore medical research studies available worldwide

Austria

1000+ Trials
100+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Belgium

2100+ Trials
300+ centers
Latest trial:
Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

Bulgaria

800+ Trials
400+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Croatia

200+ Trials
62 centers
Latest trial:
A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Cyprus

16 Trials
5 centers
Latest trial:
Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

Czechia

1400+ Trials
600+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Denmark

1400+ Trials
100+ centers
Latest trial:
Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

Estonia

100+ Trials
45 centers
Latest trial:
Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

Finland

500+ Trials
100+ centers
Latest trial:
Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

France

4100+ Trials
1000+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Germany

3500+ Trials
2100+ centers
Latest trial:
Testing benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis

Greece

1000+ Trials
100+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Guadeloupe

2 Trials
1 centers
Latest trial:
Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

Hungary

1200+ Trials
300+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Iceland

30 Trials
2 centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

India

0 Trials
1 centers

Ireland

400+ Trials
48 centers
Latest trial:
Study of intravenous melatonin safety and dosing in newborns with moderate to severe hypoxic-ischaemic encephalopathy receiving therapeutic hypothermia treatment

Israel

0 Trials
1 centers

Italy

3500+ Trials
500+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Latvia

200+ Trials
82 centers
Latest trial:
Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Lithuania

200+ Trials
78 centers
Latest trial:
Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Luxembourg

33 Trials
4 centers
Latest trial:
A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer

Norfolk Island

0 Trials
1 centers

Norway

600+ Trials
100+ centers
Latest trial:
Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

Poland

2600+ Trials
1600+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Portugal

700+ Trials
88 centers
Latest trial:
A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Réunion

2 Trials
6 centers
Latest trial:
Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

Romania

700+ Trials
400+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Slovakia

400+ Trials
300+ centers
Latest trial:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Slovenia

100+ Trials
26 centers
Latest trial:
RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Spain

4300+ Trials
500+ centers
Latest trial:
Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

Sweden

1000+ Trials
100+ centers
Latest trial:
Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

The Netherlands

2200+ Trials
200+ centers
Latest trial:
Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

United Kingdom

2 Trials
1 centers
Latest trial:
Study of Atropine Sulfate eye drops (0.

United States

2 Trials
2 centers
Latest trial:
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease